Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Curr Opin Lipidol. 2017 Apr;28(2):113–119. doi: 10.1097/MOL.0000000000000389

Table 2.

Associations for plasma lipid fractions and risk of cardiometabolic disease

Lipid
fraction
Risk of coronary
artery disease:
genetic estimate
Risk of coronary
artery disease:
RCT evidence
Risk of type 2
diabetes:
genetic estimate
Risk of type 2
diabetes: RCT
evidence
Lower LDL cholesterol Reduced[2628] Reduced[6, 23] Increased[39, 40] Increased[37]
Higher HDL cholesterol Null[2628] Null[4649] Reduced[40] No evidence
Lower Triglycerides Reduced[25, 26] No direct evidence but some indirect evidence for reduced risk[50] Reduced[40] No evidence

LDL = low-density lipoproteins; HDL = high-density lipoproteins; Genetic estimate refers to Mendelian randomization studies including multiple genetic variants affecting the trait; RCT evidence = results from randomized control trials of drugs focused primarily on modifying that lipid trait.